Voedingsadvies bij HFE-hemochromatose - Wageningen UR

Voedingsadvies bij HFE-hemochromatose
19. (NIV), N.I.V., N.V.v.K.C.e.L.e.V.A.L. (NVKC-VAL), and N.H.G.N. in samenwerking met Nederlands
Genootschap voor Maag-Darm-Leverartsen (MDL), Nederlandse Vereniging voor Bloedtransfusie (NVB),
Nederlandse Vereniging voor Hematologie (NVvH), Nederlandse Vereniging voor Pathologie (NVVP),
Nederlandse Vereniging voor Radiologie (NVR), Nederlanse Vereniging voor Reumatologie (NVvR),
Vereniging Klinische Genetica Nederland (VKGN), Hemachromatose Vereniging Nederland (HVN) met
ondersteuning van Commissie richtlijnenontwikkeling van de NIV, Kwaliteitsinstituut voor de
gezondheidszorg CBO, Diagnostiek en behandeling van hereditaire hemochromatose. 2007.
20. EASL clinical practice guidelines for HFE hemochromatosis, in J Hepatol, E.A.F.T.S.O.T. Liver, Editor.
2010. p. 3-22.
21. Janssen, M.C. and D.W. Swinkels, Hereditary haemochromatosis. Best Pract Res Clin Gastroenterol,
2009. 23(2): p. 171-83.
22. Witte, D.L., et al., Practice guideline development task force of the College of American Pathologists.
Hereditary hemochromatosis. Clin Chim Acta, 1996. 245(2): p. 139-200.
23. Roe, M.A., et al., Plasma hepcidin concentrations significantly predict interindividual variation in iron
absorption in healthy men. Am J Clin Nutr, 2009. 89(4): p. 1088-91.
24. Choudhry, V.P., Hepicidin and its role in iron metabolism. Indian J Pediatr, 2010. 77(7): p. 787-8.
25. Anderson, G.J., D.M. Frazer, and G.D. McLaren, Iron absorption and metabolism. Curr Opin
Gastroenterol, 2009. 25(2): p. 129-35.
26. Chua, A.C., et al., Iron: an emerging factor in colorectal carcinogenesis. World J Gastroenterol, 2010.
16(6): p. 663-72.
27. Mithen, R. and R. Hurrell, Effect of genotype on micronutrient absorption and metabolism: a review of
iron, copper, iodine and selenium, and folates. Int J Vitam Nutr Res, 2007. 77(3): p. 205-16.
28. Nunez, M.T., Regulatory mechanisms of intestinal iron absorption-uncovering of a fast-response
mechanism based on DMT1 and ferroportin endocytosis. BioFactors, 2010. 36(2): p. 88-97.
29. Simpson, R.J. and A.T. McKie, Regulation of intestinal iron absorption: the mucosa takes control? Cell
Metab, 2009. 10(2): p. 84-7.
30. Pietrangelo, A., Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment.
Gastroenterology, 2010. 139(2): p. 393-408, 408 e1-2.
31. Dooley, J. and M. Worwood, Guidelines on diagnosis and therapy: genetic haemochromatosis. British
Committee for Standards in Haematology, 2000: p. 1–33.
32. Arnold, J., et al., Defective release of Hepcidin not defective synthesis is the primary pathogenic
mechanism in HFE-Haemochromatosis. Med Hypotheses, 2008. 70(6): p. 1197-200.
33. Adams, P.C. and J.C. Barton, How I treat hemochromatosis. Blood, 2010. 22: p. 22.
34. Hutchinson, C., et al., Proton pump inhibitors suppress absorption of dietary non-haem iron in
hereditary haemochromatosis. Gut, 2007. 56(9): p. 1291.
Wageningen UR, Wetenschapswinkel -18- Bijlagen bij rapport 279